Their pharmacological action is through the reduction of insulin resistance by sensitizing muscle, liver, and adipose tissue to insulin, and treatment is associated with delayed progression to type 2 diabetes [5,6]. The gene discussed is INS; the disease is type 2 diabetes mellitus.